The funding will serve to support the sales efforts for the company’s swallowing disorders device. Thus far, the company has raised $3.2 million from investors.
The company was founded by JoAnne Robbins, PhD, CCC-SLP, BCS-S, of the University of Wisconsin School of Medicine and Public Health in Madison, in 2004.
More articles on gastroenterology:
Actavis completes $70.5B Allergan acquisition
4 new GI centers & partnerships
AGA: Young investigators award deadline extended
